Praxis Precision Medicine... (PRAX)
NASDAQ: PRAX
· Real-Time Price · USD
43.77
-0.53 (-1.20%)
At close: Jun 16, 2025, 3:59 PM
43.81
0.10%
After-hours: Jun 16, 2025, 04:20 PM EDT
-1.20% (1D)
| Bid | 36.1 |
| Market Cap | 891.45M |
| Revenue (ttm) | 8.12M |
| Net Income (ttm) | -212.56M |
| EPS (ttm) | -10.66 |
| PE Ratio (ttm) | -4.11 |
| Forward PE | -3.89 |
| Analyst | Buy |
| Ask | 45.67 |
| Volume | 105,568 |
| Avg. Volume (20D) | 424,492 |
| Open | 44.76 |
| Previous Close | 44.30 |
| Day's Range | 43.06 - 44.76 |
| 52-Week Range | 26.70 - 91.83 |
| Beta | 2.62 |
About PRAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-13.08%
Praxis Precision Mediciines shares are trading low...
Unlock content with
Pro Subscription
3 months ago
-40.64%
Praxis Precision Medicines shares are trading lower after the company reported a Q4 EPS miss.
3 months ago · seekingalpha.com
Praxis: A High-Risk, High-Reward Epilepsy Play Post Ulixacaltamide (Rating Upgrade)Ulixacaltamide's Phase 3 study was recommended to stop for futility, significantly lowering its chances of success in essential tremor. Investor focus shifts to the epilepsy pipeline, led by vormatrig...